These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15614047)

  • 1. Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation.
    Otto M; Barfield RC; Iyengar R; Gatewood J; Müller I; Holladay MS; Houston J; Leung W; Handgretinger R
    J Immunother; 2005; 28(1):73-8. PubMed ID: 15614047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma.
    Otto M; Barfield RC; Martin WJ; Iyengar R; Leung W; Leimig T; Chaleff S; Gillies SD; Handgretinger R
    Clin Cancer Res; 2005 Dec; 11(23):8486-91. PubMed ID: 16322312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors.
    Beloki L; Ramírez N; Olavarría E; Samuel ER; Lowdell MW
    Cytotherapy; 2014 Oct; 16(10):1390-408. PubMed ID: 24954783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of highly suppressive CD25+FoxP3+ T regulatory cells from G-CSF-mobilized donors with retention of cytotoxic anti-viral CTLs: application for multi-functional immunotherapy post stem cell transplantation.
    Samuel ER; Beloki L; Newton K; Mackinnon S; Lowdell MW
    PLoS One; 2014; 9(1):e85911. PubMed ID: 24465783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15.
    Xiong Y; Mouginot M; Reppel L; Qian C; Stoltz JF; Bensoussan D; Decot V
    Immunol Res; 2017 Dec; 65(6):1130-1138. PubMed ID: 29019081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation.
    Xuan L; Wu X; Qiu D; Gao L; Liu H; Fan Z; Huang F; Jin Z; Sun J; Li Y; Liu Q
    J Transl Med; 2018 May; 16(1):144. PubMed ID: 29801459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function.
    Samuel ER; Newton K; Mackinnon S; Lowdell MW
    Br J Haematol; 2013 Jan; 160(1):87-100. PubMed ID: 23043413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral blood.
    Beloki L; Ciaurriz M; Mansilla C; Zabalza A; Perez-Valderrama E; Samuel ER; Lowdell MW; Ramirez N; Olavarria E
    J Transl Med; 2015 May; 13():165. PubMed ID: 25990023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of human γδ T cells transducted with CD8 and with T-cell receptors of tumor-specific cytotoxic T lymphocytes.
    Hanagiri T; Shigematsu Y; Kuroda K; Baba T; Shiota H; Ichiki Y; Nagata Y; Yasuda M; So T; Takenoyama M; Tanaka F
    Cancer Sci; 2012 Aug; 103(8):1414-9. PubMed ID: 22621620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy.
    Meehan KR; Wu J; Webber SM; Barber A; Szczepiorkowski ZM; Sentman C
    Cytotherapy; 2008; 10(1):30-7. PubMed ID: 18202972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
    Harrer DC; Simon B; Fujii SI; Shimizu K; Uslu U; Schuler G; Gerer KF; Hoyer S; Dörrie J; Schaft N
    BMC Cancer; 2017 Aug; 17(1):551. PubMed ID: 28818060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeostatic γδ T Cell Contents Are Preserved by Granulocyte Colony-Stimulating Factor Priming and Correlate with the Early Recovery of γδ T Cell Subsets after Haploidentical Hematopoietic Stem Cell Transplantation.
    Bian Z; Xu LP; Fu Q; Huo M; Liu L; Zhao X; Huang XJ; Liu J
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):252-259. PubMed ID: 29061533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic β-Adrenergic Receptor Activation Augments the
    Baker FL; Bigley AB; Agha NH; Pedlar CR; O'Connor DP; Bond RA; Bollard CM; Katsanis E; Simpson RJ
    Front Immunol; 2019; 10():3082. PubMed ID: 32038628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
    Cooper LJ; Ausubel L; Gutierrez M; Stephan S; Shakeley R; Olivares S; Serrano LM; Burton L; Jensen MC; Forman SJ; DiGiusto DL
    Cytotherapy; 2006; 8(2):105-17. PubMed ID: 16698684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro expansion of human γδ and CD56(+) T-cells by Aspergillus-antigen loaded fast dendritic cells in the presence of exogenous interleukin-12.
    Ramadan G
    Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):309-16. PubMed ID: 21854188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.
    Knight A; Mackinnon S; Lowdell MW
    Cytotherapy; 2012 Oct; 14(9):1110-8. PubMed ID: 22800570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells.
    Oberg HH; Peipp M; Kellner C; Sebens S; Krause S; Petrick D; Adam-Klages S; Röcken C; Becker T; Vogel I; Weisner D; Freitag-Wolf S; Gramatzki M; Kabelitz D; Wesch D
    Cancer Res; 2014 Mar; 74(5):1349-60. PubMed ID: 24448235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
    Körbling M; Giralt S; Khouri I; Mirza N; Donato M; Anderlini P; Fischer H; Andreeff M; McMannis J; Champlin R
    J Clin Apher; 2001; 16(2):82-7. PubMed ID: 11746533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.